Letters

Clomipramine and neuroleptic malignant syndrome

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7494.791 (Published 31 March 2005) Cite this as: BMJ 2005;330:791

Authors' reply

  1. Alison Haddow (alison.haddow@gpct.Grampian.scot.nhs.uk), consultant in old age psychiatry,
  2. Martin Wilson, clinical lecturer
  1. Royal Cornhill Hospital, Aberdeen AB25 2ZH
  2. Department of Medicine for the Elderly, University of Aberdeen, Aberdeen AB25 2ZD

    EDITOR—Clomipramine is not a neuroleptic and is classed as an “antidepressant.” However, as mentioned in our article, this drug has an appreciable blocking effect at dopamine receptor sites, the traditional domain of the neuroleptic drug. This is a weak effect, but it is more potent than several …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe